Literature DB >> 23560660

Expression of the human FSHD-linked DUX4 gene induces neurogenesis during differentiation of murine embryonic stem cells.

Abhijit Dandapat1, Lynn M Hartweck, Darko Bosnakovski, Michael Kyba.   

Abstract

Misexpression of the double homeodomain protein DUX4 in muscle is believed to cause facioscapulohumeral muscular dystrophy (FSHD). Although strategies are being devised to inhibit DUX4 activity in FSHD, there is little known about the normal function of this protein. Expression of DUX4 has been reported in pluripotent cells and testis. To test the idea that DUX4 may be involved in initiating a germ lineage program in pluripotent cells, we interrogated the effect of expressing the human DUX4 gene at different stages during in vitro differentiation of murine embryonic stem (ES) cells. We find that expression of even low levels of DUX4 is incompatible with pluripotency: DUX4-expressing ES cells downregulate pluripotency markers and rapidly differentiate even in the presence of leukemia inhibitory factor (LIF) and bone morphogenetic protein 4 (BMP4). Transcriptional profiling revealed unexpectedly that DUX4 induced a neurectodermal program. Embryoid bodies exposed to a pulse of DUX4 expression displayed severely inhibited mesodermal differentiation, but acquired neurogenic potential. In a serum-containing medium in which neurogenic differentiation is minimal, DUX4 expression served as a neural-inducing factor, enabling the differentiation of Tuj1+ neurites. These data suggest that besides effects in muscle and germ cells, the involvement of DUX4 in neurogenesis should be considered as anti-DUX4 therapies are developed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23560660      PMCID: PMC3749711          DOI: 10.1089/scd.2012.0643

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  34 in total

1.  Pax7 is required for the specification of myogenic satellite cells.

Authors:  P Seale; L A Sabourin; A Girgis-Gabardo; A Mansouri; P Gruss; M A Rudnicki
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

2.  Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.

Authors:  Y Hiroi; S Kudoh; K Monzen; Y Ikeda; Y Yazaki; R Nagai; I Komuro
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 3.  Untangling the functional potential of PSA-NCAM-expressing cells in CNS development and brain repair strategies.

Authors:  Laurent Nguyen; Jean-Michel Rigo; Brigitte Malgrange; Gustave Moonen; Shibeshih Belachew
Journal:  Curr Med Chem       Date:  2003-10       Impact factor: 4.530

4.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.

Authors:  C Wijmenga; J E Hewitt; L A Sandkuijl; L N Clark; T J Wright; H G Dauwerse; A M Gruter; M H Hofker; P Moerer; R Williamson
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

5.  Early stages in the development of spinal motor neurons.

Authors:  E W Chen; A Y Chiu
Journal:  J Comp Neurol       Date:  1992-06-15       Impact factor: 3.215

6.  Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12.

Authors:  S E Holmes; E E O'Hearn; M G McInnis; D A Gorelick-Feldman; J J Kleiderlein; C Callahan; N G Kwak; R G Ingersoll-Ashworth; M Sherr; A J Sumner; A H Sharp; U Ananth; W K Seltzer; M A Boss; A M Vieria-Saecker; J T Epplen; O Riess; C A Ross; R L Margolis
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

7.  FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit.

Authors:  J C van Deutekom; C Wijmenga; E A van Tienhoven; A M Gruter; J E Hewitt; G W Padberg; G J van Ommen; M H Hofker; R R Frants
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

8.  Divergent functions of murine Pax3 and Pax7 in limb muscle development.

Authors:  Frédéric Relaix; Didier Rocancourt; Ahmed Mansouri; Margaret Buckingham
Journal:  Genes Dev       Date:  2004-05-01       Impact factor: 11.361

9.  Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.

Authors:  Takako Iida Jones; Jennifer C J Chen; Fedik Rahimov; Sachiko Homma; Patricia Arashiro; Mary Lou Beermann; Oliver D King; Jeffrey B Miller; Louis M Kunkel; Charles P Emerson; Kathryn R Wagner; Peter L Jones
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

10.  flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors.

Authors:  T P Yamaguchi; D J Dumont; R A Conlon; M L Breitman; J Rossant
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  7 in total

1.  Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.

Authors:  Chao-Jen Wong; Jennifer L Whiddon; Ashlee T Langford; Andrea E Belleville; Stephen J Tapscott
Journal:  Hum Mol Genet       Date:  2022-05-19       Impact factor: 5.121

2.  Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.

Authors:  Louise A Moyle; Eric Blanc; Oihane Jaka; Johanna Prueller; Christopher Rs Banerji; Francesco Saverio Tedesco; Stephen Dr Harridge; Robert D Knight; Peter S Zammit
Journal:  Elife       Date:  2016-11-14       Impact factor: 8.140

3.  Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4.

Authors:  Jocelyn O Eidahl; Carlee R Giesige; Jacqueline S Domire; Lindsay M Wallace; Allison M Fowler; Susan M Guckes; Sara E Garwick-Coppens; Paul Labhart; Scott Q Harper
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

4.  Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis.

Authors:  Petr Dmitriev; Ekaterina Kiseleva; Olga Kharchenko; Evgeny Ivashkin; Andrei Pichugin; Philippe Dessen; Thomas Robert; Frédérique Coppée; Alexandra Belayew; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Andrei Vasiliev; Yegor S Vassetzky
Journal:  Oncotarget       Date:  2016-10-04

Review 5.  Facioscapulohumeral dystrophy: the path to consensus on pathophysiology.

Authors:  Rabi Tawil; Silvère M van der Maarel; Stephen J Tapscott
Journal:  Skelet Muscle       Date:  2014-06-10       Impact factor: 4.912

6.  Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.

Authors:  Eugénie Ansseau; Jocelyn O Eidahl; Céline Lancelot; Alexandra Tassin; Christel Matteotti; Cassandre Yip; Jian Liu; Baptiste Leroy; Céline Hubeau; Cécile Gerbaux; Samuel Cloet; Armelle Wauters; Sabrina Zorbo; Pierre Meyer; Isabelle Pirson; Dalila Laoudj-Chenivesse; Ruddy Wattiez; Scott Q Harper; Alexandra Belayew; Frédérique Coppée
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

7.  DNA-binding sequence specificity of DUX4.

Authors:  Yu Zhang; John K Lee; Erik A Toso; Joslynn S Lee; Si Ho Choi; Matthew Slattery; Hideki Aihara; Michael Kyba
Journal:  Skelet Muscle       Date:  2016-01-28       Impact factor: 4.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.